About this trial
Testing children, adolescents, and young adults (CAYA) for a genetic risk for cancer can help with early prevention and detection of cancers through regular follow-ups and medical care. After receiving genetic test results, CAYA may not accurately understand what their results mean, and parents are often unsure about talking with their CAYA about their genetic risk for cancer. By understanding how parents communicate with their CAYA, the investigators can improve future genetic education to reduce cancer risk.
Primary Objectives:
* Identify qualities of parent-CAYA (child, adolescent, and young adults) communication about CAYAs' genomic cancer risk, and their association with CAYAs' psychosocial and prevention outcomes. * Examine the association between sociodemographic, cancer-related, and psychosocial factors and parent-CAYA communication regarding CAYAs' genomic risk for cancer. * Identify barriers and facilitators of parent-CAYA communication regarding CAYAs' genomic risk for cancer.
Eligibility criteria
Qualifiers
Patient aged 10 to 24 years (inclusive)
Patient underwent germline genetic testing with a Pathogenic/Likely Pathogenic (P/LP) variant in a known cancer predisposition gene that increases risk for developing cancer
P/LP result disclosed to the patient
Patient has a primary caregiver willing to participate
Disqualifiers
Patient is only a carrier of a recessive variant that does not alone increase risk for cancer
Inability or unwillingness of patient or participating caregiver or to give informed consent/assent
Participating caregiver is under the age of 18 years
Patient or participating caregiver has evidence of significant cognitive deficits (per medical record) that would interfere with the ability to comprehend study questions
Trial design
Treatments tested in this trial
- Not listed